These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 29428729)
21. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123 [TBL] [Abstract][Full Text] [Related]
22. NCOA5 is correlated with progression and prognosis in luminal breast cancer. Ye XH; Huang DP; Luo RC Biochem Biophys Res Commun; 2017 Jan; 482(2):253-256. PubMed ID: 27847318 [TBL] [Abstract][Full Text] [Related]
23. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796 [TBL] [Abstract][Full Text] [Related]
24. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer. Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381 [TBL] [Abstract][Full Text] [Related]
25. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561 [TBL] [Abstract][Full Text] [Related]
26. Down-regulation of p57Kip2 induces prostate cancer in the mouse. Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241 [TBL] [Abstract][Full Text] [Related]
27. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome. Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986 [TBL] [Abstract][Full Text] [Related]
28. MLF1IP is correlated with progression and prognosis in luminal breast cancer. Huang DP; Luo RC Biochem Biophys Res Commun; 2016 Sep; 477(4):923-926. PubMed ID: 27378428 [TBL] [Abstract][Full Text] [Related]
29. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer. Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583 [TBL] [Abstract][Full Text] [Related]
30. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues. Fan GK; Xu F; Yang B; Fujieda S Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer. Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944 [TBL] [Abstract][Full Text] [Related]
32. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics. Vlachos P; Joseph B Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939 [TBL] [Abstract][Full Text] [Related]
33. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer]. Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer. Zhang XF; Liu T; Li Y; Li S Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701 [TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor. Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075 [TBL] [Abstract][Full Text] [Related]
36. High Skp2/Low p57(Kip2) Expression is Associated with Poor Prognosis in Human Breast Carcinoma. Yang C; Nan H; Ma J; Jiang L; Guo Q; Han L; Zhang Y; Nan K; Guo H Breast Cancer (Auckl); 2015; 9(Suppl 1):13-21. PubMed ID: 26309408 [TBL] [Abstract][Full Text] [Related]
37. KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A/p21 and CDKN1C/p57 Expression. Sun C; Ma P; Wang Y; Liu W; Chen Q; Pan Y; Zhao C; Qian Y; Liu J; Li W; Shu Y Dig Dis Sci; 2017 Jun; 62(6):1518-1526. PubMed ID: 28421457 [TBL] [Abstract][Full Text] [Related]